Please assess the completion status of the following clinical trial:

Trial Title: Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* TKA within 48 hours and VAS\>60 during active 45 degrees knee flexion despite conventional pain medication.~* Informed consent~* ASA 1-3~* BMI 18-40~Exclusion Criteria:~* Unable to communicate in Danish~* Allergic reactions toward drugs used in the~* Abuse of alcohol/drugs~* Unable to cooperate

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Arm RP (Type: OTHER): first blockade: ropivacaine 7,5mg/ml 30 ml second blockade: placebo: saline 30 ml
- Arm PR (Type: OTHER): first blockade: placebo: saline 30 ml second blockade: ropivacaine 7,5mg/ml 30 ml

Based on this trial design, predict the completion outcome and termination type (if applicable).